Visterra

Developer of monoclonal antibodies against infectious diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2007 groups79 employees language visterrainc.com

Registered entities

Innovation

43 patent families (20 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace steady. Cited 9,940 times.

YearFilings
20152
20165
20178
201813
201911
202011
202116
202217
202320
202427
202517
20262

Social engagement

Social engagement: 14.6K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

16 investors on record; lead investors include Polaris Partners, Lux Capital, Gates, Flagship Pioneering; 2 have since exited.

Investor typeCountShare
Venture capital956%
Other / undisclosed744%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

16 Jan 2026 · Quality Control Managers · Waltham

9 Sep 2025 · Preclinical

Based on job postings tracked across public sources.

Recent activity

6 Nov 2025
Recognition
Coming soon